Research Article

Aberrant Expression TFR1/CD71 in Gastric Cancer Identifies a Novel Potential Prognostic Marker and Therapeutic Target

Table 2

Correlation of TFR1 expression and clinicopathological characteristics.

VariablesTFR1 expressionTotalX2 value
PositiveNegative

Age (y)
≥6067259210.146
<60303363

Gender
Male74391131.9070.167
Female232043

Location
Proximal3513484.4130.110
Distal544296
Total8311

Lauren type
Intestinal type55197411.821
Diffuse type282755
Mixed type141024
Unknown022

Borrmann type
I + II5039894.1180.128
III + IV461864
Unknown112

Differentiated degree
Well/moderate216273.2250.073
Moderate-poor/poor7652128

T stage
T1+21789.035
T3+49651147

N stage
N0+N12319421.5040.220
N2+N37439113

M stage
M086541400.8200.365
M111415

TNM stage
I + II911203.0310.082
III + IV8847135

HER2
Positive171188.830
Negative8057137

PD-L1
Positive4685418.083
Negative5150101

CEA
Positive3010403.5510.060
Negative6748115

CA125
Positive103130.6680.414
Negative8755142

CA72-4
Positive246304.820
Negative7352125

AFP
Positive8083.5000.061
Negative8958147

CA19-9
Positive3516511.1870.276
Negative6242104